332 related articles for article (PubMed ID: 30246507)
21. The Association Between Helicobacter pylori Infection and Nonalcoholic Fatty Liver Disease.
Tang DM; Kumar S
Curr Gastroenterol Rep; 2017 Feb; 19(2):5. PubMed ID: 28155087
[TBL] [Abstract][Full Text] [Related]
22. The effect of a low fructose and low glycemic index/load (FRAGILE) dietary intervention on indices of liver function, cardiometabolic risk factors, and body composition in children and adolescents with nonalcoholic fatty liver disease (NAFLD).
Mager DR; Iñiguez IR; Gilmour S; Yap J
JPEN J Parenter Enteral Nutr; 2015 Jan; 39(1):73-84. PubMed ID: 23976771
[TBL] [Abstract][Full Text] [Related]
23. Gamma glutamyl transferase is an independent determinant for the association of insulin resistance with nonalcoholic fatty liver disease in Bangladeshi adults: Association of GGT and HOMA-IR with NAFLD.
Hossain IA; Rahman Shah MM; Rahman MK; Ali L
Diabetes Metab Syndr; 2016; 10(1 Suppl 1):S25-9. PubMed ID: 26482965
[TBL] [Abstract][Full Text] [Related]
24. Helicobacter pylori infection might have a potential role in hepatocyte ballooning in nonalcoholic fatty liver disease.
Sumida Y; Kanemasa K; Imai S; Mori K; Tanaka S; Shimokobe H; Kitamura Y; Fukumoto K; Kakutani A; Ohno T; Taketani H; Seko Y; Ishiba H; Hara T; Okajima A; Yamaguchi K; Moriguchi M; Mitsuyoshi H; Yasui K; Minami M; Itoh Y
J Gastroenterol; 2015 Sep; 50(9):996-1004. PubMed ID: 25622927
[TBL] [Abstract][Full Text] [Related]
25. Serum concentration of adiponectin, leptin and resistin in obese children with non-alcoholic fatty liver disease.
Lebensztejn DM; Wojtkowska M; Skiba E; Werpachowska I; Tobolczyk J; Kaczmarski M
Adv Med Sci; 2009; 54(2):177-82. PubMed ID: 20022856
[TBL] [Abstract][Full Text] [Related]
26. Helicobacter pylori infection is not associated with fatty liver disease including non-alcoholic fatty liver disease: a large-scale cross-sectional study in Japan.
Okushin K; Takahashi Y; Yamamichi N; Shimamoto T; Enooku K; Fujinaga H; Tsutsumi T; Shintani Y; Sakaguchi Y; Ono S; Kodashima S; Fujishiro M; Moriya K; Yotsuyanagi H; Mitsushima T; Koike K
BMC Gastroenterol; 2015 Feb; 15():25. PubMed ID: 25880912
[TBL] [Abstract][Full Text] [Related]
27. Central obesity and altered peripheral adipose tissue gene expression characterize the NAFLD patient with insulin resistance: Role of nutrition and insulin challenge.
Paniagua JA; Escandell-Morales JM; Gil-Contreras D; Berral de la Rosa FJ; Romero-Jimenez M; Gómez-Urbano A; Sanchez-Lopez A; Bellido E; Poyato A; Calatayud B; Vidal-Puig AJ
Nutrition; 2014 Feb; 30(2):177-85. PubMed ID: 24377452
[TBL] [Abstract][Full Text] [Related]
28. Potential role of Helicobacter pylori infection in nonalcoholic fatty liver disease.
Li M; Shen Z; Li YM
World J Gastroenterol; 2013 Nov; 19(41):7024-31. PubMed ID: 24222944
[TBL] [Abstract][Full Text] [Related]
29. A pilot study of the effects of chromium picolinate supplementation on serum fetuin-A, metabolic and inflammatory factors in patients with nonalcoholic fatty liver disease: A double-blind, placebo-controlled trial.
Moradi F; Kooshki F; Nokhostin F; Khoshbaten M; Bazyar H; Pourghassem Gargari B
J Trace Elem Med Biol; 2021 Jan; 63():126659. PubMed ID: 33045675
[TBL] [Abstract][Full Text] [Related]
30. Investigation of adropin and leptin levels in pediatric obesity-related nonalcoholic fatty liver disease.
Sayın O; Tokgöz Y; Arslan N
J Pediatr Endocrinol Metab; 2014 May; 27(5-6):479-84. PubMed ID: 24468600
[TBL] [Abstract][Full Text] [Related]
31. [Correlation between the inflammatory factors and adipocytokines with gestational diabetes mellitus and their change in puerperium].
Liu T; Fang Z; Yang D; Liu Q
Zhonghua Fu Chan Ke Za Zhi; 2012 Jun; 47(6):436-9. PubMed ID: 22932110
[TBL] [Abstract][Full Text] [Related]
32. The relationship of circulating fetuin-a with liver histology and biomarkers of systemic inflammation in nondiabetic subjects with nonalcoholic fatty liver disease.
Celebi G; Genc H; Gurel H; Sertoglu E; Kara M; Tapan S; Acikel C; Karslioglu Y; Ercin CN; Dogru T
Saudi J Gastroenterol; 2015; 21(3):139-45. PubMed ID: 26021772
[TBL] [Abstract][Full Text] [Related]
33. Serum adipokine levels predictive of liver injury in non-alcoholic fatty liver disease.
Lemoine M; Ratziu V; Kim M; Maachi M; Wendum D; Paye F; Bastard JP; Poupon R; Housset C; Capeau J; Serfaty L
Liver Int; 2009 Oct; 29(9):1431-8. PubMed ID: 19422483
[TBL] [Abstract][Full Text] [Related]
34. Adiponectin-leptin ratio for the early detection of lean non-alcoholic fatty liver disease independent of insulin resistance.
Lu CW; Yang KC; Chi YC; Wu TY; Chiang CH; Chang HH; Huang KC; Yang WS
Ann Med; 2023 Dec; 55(1):634-642. PubMed ID: 36790383
[TBL] [Abstract][Full Text] [Related]
35. NAFLD, Helicobacter species and the intestinal microbiome.
Castaño-Rodríguez N; Mitchell HM; Kaakoush NO
Best Pract Res Clin Gastroenterol; 2017 Dec; 31(6):657-668. PubMed ID: 29566909
[TBL] [Abstract][Full Text] [Related]
36. Long-term effects of aerobic plus resistance training on the adipokines and neuropeptides in nonalcoholic fatty liver disease obese adolescents.
de Piano A; de Mello MT; Sanches Pde L; da Silva PL; Campos RM; Carnier J; Corgosinho F; Foschini D; Masquio DL; Tock L; Oyama LM; do Nascimento CM; Tufik S; Dâmaso AR
Eur J Gastroenterol Hepatol; 2012 Nov; 24(11):1313-24. PubMed ID: 22932160
[TBL] [Abstract][Full Text] [Related]
37. Hepatic insulin resistance in NAFLD: relationship with markers of atherosclerosis and metabolic syndrome components.
Privitera G; Spadaro L; Alagona C; Calanna S; Piro S; Rabuazzo AM; Purrello F
Acta Diabetol; 2016 Jun; 53(3):449-59. PubMed ID: 26496770
[TBL] [Abstract][Full Text] [Related]
38. Severity of non-alcoholic fatty liver disease is associated with high systemic levels of tumor necrosis factor alpha and low serum interleukin 10 in morbidly obese patients.
Paredes-Turrubiarte G; González-Chávez A; Pérez-Tamayo R; Salazar-Vázquez BY; Hernández VS; Garibay-Nieto N; Fragoso JM; Escobedo G
Clin Exp Med; 2016 May; 16(2):193-202. PubMed ID: 25894568
[TBL] [Abstract][Full Text] [Related]
39. Serum C1q/TNF-related protein 9 is not related to nonalcoholic fatty liver disease.
Zhang C; Zhou N; Qiu P; Fu Y; Liu Z; Li H; Yang X; Zhang L
Cytokine; 2018 Oct; 110():52-57. PubMed ID: 29704818
[TBL] [Abstract][Full Text] [Related]
40. Increased Plasma Levels of Asymmetric Dimethylarginine in Nonalcoholic Fatty Liver Disease: Relation With Insulin Resistance, Inflammation, and Liver Histology.
Boga S; Alkim H; Koksal AR; Bayram M; Ozguven MB; Ergun M; Neijmann ST; Ozgon G; Alkim C
J Investig Med; 2015 Oct; 63(7):871-7. PubMed ID: 26244718
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
